Reference

CMO(2023)11

Name

Shingles vaccination programme: Introduction of Shingrix® vaccine for the whole programme and expansion of eligible cohorts

Categories

Scottish Government CMO Letters

Organization

Scottish Government Health and Social Care Directorates

Keywords

NHS SCOTLAND SHINGLES VACCINATION SHINGRIX JCVI ZOSTAVAX

Description

This letter provides information on the changes to the 2023/24 shingles vaccination programme which will run from 1 September 2023 to 31 August 2024. The aim of the national shingles vaccination programme is to protect those most at risk from shingles and its complications such as post herpetic neuralgia. Although shingles can occur at any age, the risk and severity of shingles and its complications increases with age and is high in individuals who are severely immunosuppressed. It is important to ensure that those at greatest risk are vaccinated at an earlier age and this forms the basis of the Joint Committee on Vaccination and Immunisation (JCVI) recommendations. The shingles vaccination programme was introduced in Scotland in 2013 for those aged 70 years old. A catch up programme for those aged 71 to 79 years old was also introduced at this time, and was rolled out over a number of years. Zostavax®, a live vaccine, was routinely offered to those eligible and not contraindicated to the vaccine. Since September 2021, Shingrix®, a non-live vaccine, has been available to immunocompromised individuals aged 70 to 79 years, who are contraindicated to receive Zostavax®, as part of the NHS shingles vaccination programme.

Contact Name

Contact Email

Contact Address

Contact Phone

Created

2023-07-31 00:00:00

Download URL